• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY MITEK LLC US BIO-INTRAFIX TIBIAL SHEATH - LARGE; SOFT-TISSUE ANCHOR, BIOABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY MITEK LLC US BIO-INTRAFIX TIBIAL SHEATH - LARGE; SOFT-TISSUE ANCHOR, BIOABSORBABLE Back to Search Results
Model Number 254628
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Foreign Body Reaction (1868); Inflammation (1932)
Date of Event 01/17/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This report is being submitted in pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by depuy mitek or its employees that the report constitutes an admission that the device, depuy mitek, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Additional narrative: udi: (b)(4).Initial reporter occupation: reporter is a j&j sales representative.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.
 
Event or Problem Description
This is report 1 of 2 for (b)(4).It was reported by the sales rep in china that a patient underwent an arthroscopic reconstruction procedure for anterior cruciate ligament injury on (b)(6) 2022; and was implanted with two biointrafix implants; bio-intrafix tibial sheath - large device and bio-intrafix tapered screw, 7-9 mm x 30 mm device.According to the report, the patient developed rejection with persistent low-grade fever three months after the initial procedure.It was further reported that a second surgery was undergone to remove the implants on (b)(6) 2023.And the peek implants were replaced for implanting.It was reported that the patient was in stable condition now.No additional information was provided.
 
Additional Manufacturer Narrative
This report is being submitted in pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by depuy mitek or its employees that the report constitutes an admission that the device, depuy mitek, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed a appropriate.H10 additional narrative: investigation summary: the complaint device is not being returned, therefore unavailable for a physical evaluation, however a photo was provided.Upon visual inspection of the photo, the biointrafix sheath (254628) is shown inside a transparent plastic bag.No structural anomalies can be observed, however, a little part of the sheath is broken due to the removal procedure.The device has biological matter on its body which is a sign that it was removed from the patient's body.A manufacturing record evaluation was performed for the finished device 9l05327 number, and no non-conformances were identified.As part of depuy synthes mitek quality process all devices are manufactured, inspected, and released to approved specifications.Since there is no allegation against the product, we cannot determine a root cause for the reported issue.At this point in time, no corrective action is required, and no further action is warranted.However, depuy synthes mitek will continue to monitor additional complaint information for potential safety signals through complaint trending as part of post market surveillance.
 
Additional Manufacturer Narrative
This report is being submitted in pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by depuy mitek or its employees that the report constitutes an admission that the device, depuy mitek, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.D9, h3, h6: the actual device has been returned and is currently pending evaluation.Once reliability engineering evaluates the device, a supplemental medwatch report will be sent accordingly.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Additional Manufacturer Narrative
This report is being submitted in pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by depuy mitek or its employees that the report constitutes an admission that the device, depuy mitek, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Investigation summary: the complaint devices were received and evaluated.Upon visual inspection, the screw is inserted into the sheath.No structural anomalies can be observed, however, a little part of the sheath is broken due to the removal procedure.The devices have biological matter on their body which is a sign that it was removed from the patient's body.A manufacturing record evaluation was performed for the finished device 9l05327 number, and no non-conformances were identified.As part of depuy synthes mitek quality process all devices are manufactured, inspected, and released to approved specifications.Since there is no allegation against the product, we cannot determine a root cause for the reported issue.At this point in time, no corrective action is required, and no further action is warranted.However, depuy synthes mitek will continue to monitor additional complaint information for potential safety signals through complaint trending as part of post market surveillance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIO-INTRAFIX TIBIAL SHEATH - LARGE
Common Device Name
SOFT-TISSUE ANCHOR, BIOABSORBABLE
Manufacturer (Section D)
DEPUY MITEK LLC US
325 paramount drive
raynham MA 02767
Manufacturer (Section G)
DEPUY MITEK LLC US
325 paramount drive
raynham MA 02767
Manufacturer Contact
kate karberg
325 paramount drive
raynham, MA 02767
3035526892
MDR Report Key16373532
Report Number1221934-2023-00744
Device Sequence Number6748847
Product Code HWC
UDI-Device Identifier10886705013241
UDI-Public10886705013241
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K032167
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/31/2025
Device Model Number254628
Device Catalogue Number254628
Device Lot Number9L05327
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/30/2023
Supplement Date Received by Manufacturer02/16/2023
02/20/2023
03/10/2023
Initial Report FDA Received Date02/14/2023
Supplement Report FDA Received Date02/17/2023
02/21/2023
03/14/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/21/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-